Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic myeloid leukemia
Pharma
FDA approves Shorla's oral liquid version of Novartis' Gleevec
Shorla has scored an FDA nod for its strawberry-flavored drink version of Novartis' Gleevec.
Kevin Dunleavy
Nov 26, 2024 11:18am
Azurity scores FDA nod for new formulation of Novartis' Tasigna
Nov 15, 2024 10:55am
Novartis' Scemblix leaps into newly diagnosed CML
Oct 29, 2024 3:56pm
MediLink, Takeda, Ascentage and China NMPA—Fierce Pharma Asia
Jun 21, 2024 8:23am
Takeda circles Ascentage's Scemblix challenger for up to $1.3B
Jun 14, 2024 11:30am
ASCO: Novartis' Scemblix proves benefits over Gleevec in CML
May 31, 2024 8:00am
